Hepatitis A Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Hepatitis A stocks.

Hepatitis A Stocks Recent News

Date Stock Title
Nov 21 IVA Inventiva S.A reports 9M results
Nov 21 IVA Inventiva reports 2024 Third Quarter Financial Information¹
Nov 20 IVA Statement of total voting rights and shares forming the company’s share capital as of November 4, 2024
Nov 20 IVA Combined General Meeting of December 11, 2024 - Availability of the preparatory documents
Nov 20 GSK CDC warns of an imminent spike in COVID, flu cases
Nov 19 GSK GSK's Investigational Liver Disease Candidate Hits Primary Goal In Late-Stage Study To Treat Relentless Itch In Some Patients
Nov 19 GSK GSK's Investigational Liver Disease Candidate Hits Primary Goal In Late-Stage Study To Treat Relentless Itch In Some Patients
Nov 19 GSK GSK reports positive Phase 3 results for linerixibat in PBC itching
Nov 18 GSK Medicus Pharma Ltd. Appoints Faisal Mehmud, MD, MRCP as Chief Medical Officer
Nov 18 IVA The first MASH drug could open the door for others — including GLP-1s
Nov 15 GSK How analysts are reacting to RFK Jr. as Trump's HHS pick
Nov 15 IVA Inventiva will present data from the final analysis of the Phase 2 study evaluating the combination of lanifibranor with empagliflozin in patients with MASH and T2D at the AASLD The Liver Meeting® late-breaker session
Nov 15 GSK Stocks to Watch Friday: Applied Materials, Alibaba, Domino's, Novo Nordisk
Nov 15 GSK Vaccine stocks drop on concerns about RFK Jr. heading HHS (update)
Nov 15 GSK GSK plc (GSK) Guggenheim's Inaugural Healthcare Innovation Conference (Transcript)
Nov 15 GSK Trump’s RFK Jr. Pick Weighs on Vaccine Makers
Nov 15 GSK Trump looks to end EV credit, vaccine stocks fall on RFK JR. pick
Nov 15 GSK Analysts think Wall Street's reaction to the RFK Jr. news is 'overdone.' Sort of.
Nov 15 GSK European Vaccine Makers Under Pressure After Trump Picks RFK Jr to Lead Health Department
Hepatitis A

Hepatitis A is an infectious disease of the liver caused by the hepatitis A virus (HAV). Many cases have few or no symptoms, especially in the young. The time between infection and symptoms, in those who develop them, is between two and six weeks. When symptoms occur, they typically last eight weeks and may include nausea, vomiting, diarrhea, jaundice, fever, and abdominal pain. Around 10–15% of people experience a recurrence of symptoms during the six months after the initial infection. Acute liver failure may rarely occur, with this being more common in the elderly.It is usually spread by eating food or drinking water contaminated with infected feces. Shellfish which have not been sufficiently cooked are a relatively common source. It may also be spread through close contact with an infectious person. While children often do not have symptoms when infected, they are still able to infect others. After a single infection, a person is immune for the rest of his or her life. Diagnosis requires blood testing, as the symptoms are similar to those of a number of other diseases. It is one of five known hepatitis viruses: A, B, C, D, and E.
The hepatitis A vaccine is effective for prevention. Some countries recommend it routinely for children and those at higher risk who have not previously been vaccinated. It appears to be effective for life. Other preventive measures include hand washing and properly cooking food. No specific treatment is available, with rest and medications for nausea or diarrhea recommended on an as-needed basis. Infections usually resolve completely and without ongoing liver disease. Treatment of acute liver failure, if it occurs, is with liver transplantation.Globally, around 1.4 million symptomatic cases occur each year and about 114 million infections (symptomatic and asymptomatic). It is more common in regions of the world with poor sanitation and not enough safe water. In the developing world, about 90% of children have been infected by age 10, thus are immune by adulthood. It often occurs in outbreaks in moderately developed countries where children are not exposed when young and vaccination is not widespread. Acute hepatitis A resulted in 11,200 deaths in 2015. World Hepatitis Day occurs each year on July 28 to bring awareness to viral hepatitis.

Browse All Tags